{"title":"Interpret the estimand framework from a causal inference perspective","authors":"Jinghong Zeng","doi":"arxiv-2407.00292","DOIUrl":null,"url":null,"abstract":"The estimand framework proposed by ICH in 2017 has brought fundamental\nchanges in the pharmaceutical industry. It clearly describes how a treatment\neffect in a clinical question should be precisely defined and estimated,\nthrough attributes including treatments, endpoints and intercurrent events.\nHowever, ideas around the estimand framework are commonly in text, and\ndifferent interpretations on this framework may exist. This article aims to\ninterpret the estimand framework through its underlying theories, the causal\ninference framework based on potential outcomes. The statistical origin and\nformula of an estimand is given through the causal inference framework, with\nall attributes translated into statistical terms. How five strategies proposed\nby ICH to analyze intercurrent events are incorporated in the statistical\nformula of an estimand is described, and a new strategy to analyze intercurrent\nevents is also suggested. The roles of target populations and analysis sets in\nthe estimand framework are compared and discussed based on the statistical\nformula of an estimand. This article recommends continuing study of causal\ninference theories behind the estimand framework and improving the estimand\nframework with greater methodological comprehensibility and availability.","PeriodicalId":501323,"journal":{"name":"arXiv - STAT - Other Statistics","volume":"47 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"arXiv - STAT - Other Statistics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/arxiv-2407.00292","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The estimand framework proposed by ICH in 2017 has brought fundamental
changes in the pharmaceutical industry. It clearly describes how a treatment
effect in a clinical question should be precisely defined and estimated,
through attributes including treatments, endpoints and intercurrent events.
However, ideas around the estimand framework are commonly in text, and
different interpretations on this framework may exist. This article aims to
interpret the estimand framework through its underlying theories, the causal
inference framework based on potential outcomes. The statistical origin and
formula of an estimand is given through the causal inference framework, with
all attributes translated into statistical terms. How five strategies proposed
by ICH to analyze intercurrent events are incorporated in the statistical
formula of an estimand is described, and a new strategy to analyze intercurrent
events is also suggested. The roles of target populations and analysis sets in
the estimand framework are compared and discussed based on the statistical
formula of an estimand. This article recommends continuing study of causal
inference theories behind the estimand framework and improving the estimand
framework with greater methodological comprehensibility and availability.
2017 年 ICH 提出的估计值框架给制药行业带来了根本性的变革。它明确描述了临床问题中的治疗效果应如何通过包括治疗、终点和并发事件在内的属性进行精确定义和估算。然而,围绕estimand框架的观点常见于文本中,对这一框架可能存在不同的解释。本文旨在通过其基础理论--基于潜在结果的因果推断框架--来解释估计值框架。通过因果推理框架给出估计值的统计起源和公式,并将所有属性转化为统计术语。介绍了如何将非物质文化遗产提出的五种分析并发事件的策略纳入估算对象的统计公式,并提出了一种分析并发事件的新策略。根据估算指标的统计公式,比较并讨论了目标人群和分析集在估算指标框架中的作用。本文建议继续研究估计指标框架背后的因果推断理论,并改进估计指标框架,使其在方法上更加易懂和可用。